Safeguarding Australia's healthcare sector with a new nuclear medicine facility
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
Showing 101 - 120 of 597 results
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
Applications are now being accepted for the Industry foundations Scholarship.
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
ANSTO’s isotope tracing facilities provide a range of radioanalytical, isotopic and elemental analytical techniques, measurements and expertise for environmental studies.
The 2021 intake of bright young graduates have arrived at the ANSTO Precinct at Lucas Heights and this week will commence their exciting new career to become the nation’s future leaders in STEM and innovation.
Role at ANSTO
Dr Richard Mole is an instrument scientist co-responsible for the cold-neutron time-of-flight spectrometer PELICAN.
ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
ANSTO is interested finding students to collaborate on Generation IV reactor systems.
Accelerator technique used in pioneering biomaterials research led by the University of Sydney.
Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)
Favourable conceptual design review may lead to expanded role for Australia on ITER diagnostics.
Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.
The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.
Using the OPAL multipurpose reactor,, ANSTO can provide a diverse suite of radioisotopes for research and applications
To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.
ANSTO continually collects meteorological data from its 50-metre tower. A summary of ANSTO's climate statistics including temperature, wind speed and direction, relative humidity, atmospheric pressure and rainfall recorded at this location are provided below.
Sample environments, Data analysis, SpICE and SICS